Ulrich Blache
Papers
1
Total Citations
13
H-Index
1
About
Dr. Ulrich Blache is a leading figure in the translational development of Advanced Therapy Medicinal Products (ATMPs), with a specific focus on automating the manufacturing of tissue-engineered cartilage. His most cited work, "From Single Batch to Mass Production–Automated Platform Design Concept for a Phase II Clinical Trial Tissue Engineered Cartilage Product" (2021, 13 citations), addresses a critical bottleneck in regenerative medicine: scaling up laboratory successes into reproducible, cost-effective clinical production. Dr. Blache’s major contribution lies in bridging the gap between manual, small-scale tissue engineering and automated, GMP-compliant manufacturing platforms. By designing a concept for a Phase II clinical trial product, he has provided a roadmap for moving promising cartilage therapies from the bench to the bedside, tackling the unmet clinical needs of chronic joint diseases. His work is pivotal for researchers and bioprocess engineers seeking to industrialize ATMPs, demonstrating how automation can ensure quality, reduce costs, and accelerate patient access. Dr. Blache’s insights are essential for anyone navigating the complex journey from a single batch to mass production in regenerative medicine.
Research Focus
Key Achievements
Top Papers
- 1